Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

China’s Commerce Ministry this week said it placed Illumina, the leading maker of next-generation sequencing machines, on its list of “unreliable entities,” part of China’s retaliation ...

Illumina is a global leader in developing the tools that help scientists analyze strands of DNA as well as large amounts of complex genetic data through multiomic sequencing. Researchers and ...

SAN DIEGO, Jan. 13, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...

Over the last six months, ANGLE has overcome technical issues to successfully use Illumina assays ... Parsortix-based CTC analysis for DNA dual analysis NGS sequencing, enabling analysis of ...

Angle plc, a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, has announced new, successful ...